These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19688249)

  • 1. Convulsant activity of sitafloxacin and its interactions with anti-inflammatory drugs in mice.
    Hori S
    J Infect Chemother; 2009 Aug; 15(4):266-8. PubMed ID: 19688249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anti-inflammatory drugs on convulsant activity of quinolones: a comparative study of drug interaction between quinolones and anti-inflammatory drugs.
    Hori S; Kizu J; Kawamura M
    J Infect Chemother; 2003 Dec; 9(4):314-20. PubMed ID: 14691652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    Fukuda H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evaluation of garenoxacin, a novel des-F(6)-quinolone antimicrobial agent: effects on the central nervous system.
    Nakamura T; Fukuda H; Morita Y; Soumi K; Kawamura Y
    J Toxicol Sci; 2003 Feb; 28(1):35-45. PubMed ID: 12696183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antimicrobial activities of gatifloxacin, sitafloxacin and levofloxacin against Mycobacterium tuberculosis replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
    Sato K; Tomioka H; Sano C; Shimizu T; Sano K; Ogasawara K; Cai S; Kamei T
    J Antimicrob Chemother; 2003 Aug; 52(2):199-203. PubMed ID: 12865388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity.
    Dawe RS; Ibbotson SH; Sanderson JB; Thomson EM; Ferguson J
    Br J Dermatol; 2003 Dec; 149(6):1232-41. PubMed ID: 14674902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surveillance on concurrent administration of quinolones and anti-inflammatory drugs in a community hospital].
    Kaneda M; Tsuda J; Iida N; Igarashi T; Tajima H; Kizu J; Hori S
    Jpn J Antibiot; 2003 Aug; 56(4):272-80. PubMed ID: 14567251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse drug interactions between pyridonecarboxylic acids and nonsteroidal antiinflammatory drugs: convulsion after oral or intracerebral administration in mice].
    Hirai S; Tanaka K; Makino S; Narita H
    Yakugaku Zasshi; 1989 Feb; 109(2):119-26. PubMed ID: 2746470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice.
    Furuhama K; Akahane K; Tawara K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment.
    Loeb S
    Urology; 2011 Aug; 78(2):255-6; authro reply 256. PubMed ID: 21820566
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of side effects of levofloxacin versus other fluoroquinolones.
    Carbon C
    Chemotherapy; 2001; 47 Suppl 3():9-14; discussion 44-8. PubMed ID: 11549784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of intracameral injection of gatifloxacin, levofloxacin on corneal endothelial structure and viability.
    Choi JA; Chung SK
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):425-31. PubMed ID: 19857104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latest industry information on the safety profile of levofloxacin in Japan.
    Yagawa K
    Chemotherapy; 2001; 47 Suppl 3():38-43; discussion 44-8. PubMed ID: 11549788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizures associated with fluoroquinolones.
    Kushner JM; Peckman HJ; Snyder CR
    Ann Pharmacother; 2001 Oct; 35(10):1194-8. PubMed ID: 11675843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients.
    Lodise T; Graves J; Miller C; Mohr JF; Lomaestro B; Smith RP
    Pharmacotherapy; 2007 Nov; 27(11):1498-505. PubMed ID: 17963459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bile duct ligation and unilateral nephrectomy on brain concentration and convulsant potential of the quinolone antibacterial agent levofloxacin in rats.
    Akahane K; Ohkawara S; Nomura M; Kato M
    Fundam Appl Toxicol; 1996 Feb; 29(2):280-6. PubMed ID: 8742326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system toxicity of quinolones: human and animal findings.
    Christ W
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():219-25. PubMed ID: 2124211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central stimulating effect of the combination of the new quinolone group of antimicrobials and nonsteroidal anti-inflammatory drugs in mice].
    Murayama S; Hara Y; Ally A; Suzuki T; Tamagawa M
    Nihon Yakurigaku Zasshi; 1992 Jan; 99(1):13-8. PubMed ID: 1313777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of new quinolones on GABA(A) receptor-mediated response and its potentiation with felbinac in Xenopus oocytes injected with mouse-brain mRNA: correlation with convulsive potency in vivo.
    Kawakami J; Yamamoto K; Asanuma A; Yanagisawa K; Sawada Y; Iga T
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):246-54. PubMed ID: 9266796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin.
    Shi G; Chen X; Wang H; Wang S; Guo X; Zhang X
    J Antibiot (Tokyo); 2012 May; 65(5):229-36. PubMed ID: 22334239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.